Approximately 86% of the ESPL1+/hyp, p53−/− animals developed lymphomas with a median survival period of 118 days, compared to about 37% p53−/− animals that developed pathologically confirmed lymphomas in the same time period. This evidence concerns the gene ESPL1 and lymphoma.